Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helicobacter

Showing results (1101-1110 of 2,116) with videos related to

Pageof 212
Sort By:
Helicobacter|August 8, 2002
cag pathogenicity island of Helicobacter pylori in Korean childrenJae Sung Ko, Jeong Kee Seo
Helicobacter|August 8, 2002
Helicobacter pylori infection in connective tissue disorders is associated with high levels of antibodies to mycobacterial hsp65 but not to human hsp60László Kalabay, Béla Fekete, László Czirják, et al.
Helicobacter|August 29, 2002
Helicobacter pylori and nonmalignant diseasePaul Moayyedi, Peter Malfertheiner
Helicobacter|September 3, 2003
Treatment of Helicobacter pylori infection using a novel antiadhesion compound (3'sialyllactose sodium salt). A double blind, placebo-controlled clinical studyF Parente, C Cucino, A Anderloni, et al.
Helicobacter|September 3, 2003
Salvage therapy after two or more prior Helicobacter pylori treatment failures: the super salvage regimenMaria Pina Dore, Lea Marras, Emmanouil Maragkoudakis, et al.
Helicobacter|June 6, 2002
Enhanced expression of transcription factor E2F in Helicobacter pylori-infected gastric mucosaHajime Isomoto, Hisashi Furusu, Masashi Shin, et al.
Helicobacter|June 6, 2002
Additive effect of pronase on the efficacy of eradication therapy against Helicobacter pyloriAkira Gotoh, Taiji Akamatsu, Toshiki Shimizu, et al.
Helicobacter|November 14, 2019
Clostridium difficile-associated disease and Helicobacter pylori seroprevalence: A case-control studyKhitam Muhsen, Wasef Na'amnih, Amos Adler, et al.
Helicobacter|November 26, 2019
The relationship of gastric microbiota and Helicobacter pylori infection in pediatrics populationRuixue Miao, Chaomin Wan, Zhiling Wang
Helicobacter|February 20, 2020
Efficacy and safety of twice a day, bismuth-containing quadruple therapy using high-dose tetracycline and metronidazole for second-line Helicobacter pylori eradicationJi Yeon Kim, Sun-Young Lee, Jeong Hwan Kim, et al.
Pageof 212

Showing results (1101-1110 of 2,116) with videos related to

Sort By:
Pageof 212
Helicobacter|August 8, 2002
cag pathogenicity island of Helicobacter pylori in Korean childrenJae Sung Ko, Jeong Kee Seo
Helicobacter|August 8, 2002
Helicobacter pylori infection in connective tissue disorders is associated with high levels of antibodies to mycobacterial hsp65 but not to human hsp60László Kalabay, Béla Fekete, László Czirják, et al.
Helicobacter|August 29, 2002
Helicobacter pylori and nonmalignant diseasePaul Moayyedi, Peter Malfertheiner
Helicobacter|September 3, 2003
Treatment of Helicobacter pylori infection using a novel antiadhesion compound (3'sialyllactose sodium salt). A double blind, placebo-controlled clinical studyF Parente, C Cucino, A Anderloni, et al.
Helicobacter|September 3, 2003
Salvage therapy after two or more prior Helicobacter pylori treatment failures: the super salvage regimenMaria Pina Dore, Lea Marras, Emmanouil Maragkoudakis, et al.
Helicobacter|June 6, 2002
Enhanced expression of transcription factor E2F in Helicobacter pylori-infected gastric mucosaHajime Isomoto, Hisashi Furusu, Masashi Shin, et al.
Helicobacter|June 6, 2002
Additive effect of pronase on the efficacy of eradication therapy against Helicobacter pyloriAkira Gotoh, Taiji Akamatsu, Toshiki Shimizu, et al.
Helicobacter|November 14, 2019
Clostridium difficile-associated disease and Helicobacter pylori seroprevalence: A case-control studyKhitam Muhsen, Wasef Na'amnih, Amos Adler, et al.
Helicobacter|November 26, 2019
The relationship of gastric microbiota and Helicobacter pylori infection in pediatrics populationRuixue Miao, Chaomin Wan, Zhiling Wang
Helicobacter|February 20, 2020
Efficacy and safety of twice a day, bismuth-containing quadruple therapy using high-dose tetracycline and metronidazole for second-line Helicobacter pylori eradicationJi Yeon Kim, Sun-Young Lee, Jeong Hwan Kim, et al.
Pageof 212